Cargando…

Mast cell activation test in the diagnosis of allergic disease and anaphylaxis

BACKGROUND: Food allergy is an increasing public health issue and the most common cause of life-threatening anaphylactic reactions. Conventional allergy tests assess for the presence of allergen-specific IgE, significantly overestimating the rate of true clinical allergy and resulting in overdiagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahri, Rajia, Custovic, Adnan, Korosec, Peter, Tsoumani, Marina, Barron, Martin, Wu, Jiakai, Sayers, Rebekah, Weimann, Alf, Ruiz-Garcia, Monica, Patel, Nandinee, Robb, Abigail, Shamji, Mohamed H., Fontanella, Sara, Silar, Mira, Mills, E.N.Clare, Simpson, Angela, Turner, Paul J., Bulfone-Paus, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mosby 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075471/
https://www.ncbi.nlm.nih.gov/pubmed/29518421
http://dx.doi.org/10.1016/j.jaci.2018.01.043
_version_ 1783344591473213440
author Bahri, Rajia
Custovic, Adnan
Korosec, Peter
Tsoumani, Marina
Barron, Martin
Wu, Jiakai
Sayers, Rebekah
Weimann, Alf
Ruiz-Garcia, Monica
Patel, Nandinee
Robb, Abigail
Shamji, Mohamed H.
Fontanella, Sara
Silar, Mira
Mills, E.N.Clare
Simpson, Angela
Turner, Paul J.
Bulfone-Paus, Silvia
author_facet Bahri, Rajia
Custovic, Adnan
Korosec, Peter
Tsoumani, Marina
Barron, Martin
Wu, Jiakai
Sayers, Rebekah
Weimann, Alf
Ruiz-Garcia, Monica
Patel, Nandinee
Robb, Abigail
Shamji, Mohamed H.
Fontanella, Sara
Silar, Mira
Mills, E.N.Clare
Simpson, Angela
Turner, Paul J.
Bulfone-Paus, Silvia
author_sort Bahri, Rajia
collection PubMed
description BACKGROUND: Food allergy is an increasing public health issue and the most common cause of life-threatening anaphylactic reactions. Conventional allergy tests assess for the presence of allergen-specific IgE, significantly overestimating the rate of true clinical allergy and resulting in overdiagnosis and adverse effect on health-related quality of life. OBJECTIVE: To undertake initial validation and assessment of a novel diagnostic tool, we used the mast cell activation test (MAT). METHODS: Primary human blood-derived mast cells (MCs) were generated from peripheral blood precursors, sensitized with patients' sera, and then incubated with allergen. MC degranulation was assessed by means of flow cytometry and mediator release. We compared the diagnostic performance of MATs with that of existing diagnostic tools to assess in a cohort of peanut-sensitized subjects undergoing double-blind, placebo-controlled challenge. RESULTS: Human blood-derived MCs sensitized with sera from patients with peanut, grass pollen, and Hymenoptera (wasp venom) allergy demonstrated allergen-specific and dose-dependent degranulation, as determined based on both expression of surface activation markers (CD63 and CD107a) and functional assays (prostaglandin D(2) and β-hexosaminidase release). In this cohort of peanut-sensitized subjects, the MAT was found to have superior discrimination performance compared with other testing modalities, including component-resolved diagnostics and basophil activation tests. Using functional principle component analysis, we identified 5 clusters or patterns of reactivity in the resulting dose-response curves, which at preliminary analysis corresponded to the reaction phenotypes seen at challenge. CONCLUSION: The MAT is a robust tool that can confer superior diagnostic performance compared with existing allergy diagnostics and might be useful to explore differences in effector cell function between basophils and MCs during allergic reactions.
format Online
Article
Text
id pubmed-6075471
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Mosby
record_format MEDLINE/PubMed
spelling pubmed-60754712018-08-09 Mast cell activation test in the diagnosis of allergic disease and anaphylaxis Bahri, Rajia Custovic, Adnan Korosec, Peter Tsoumani, Marina Barron, Martin Wu, Jiakai Sayers, Rebekah Weimann, Alf Ruiz-Garcia, Monica Patel, Nandinee Robb, Abigail Shamji, Mohamed H. Fontanella, Sara Silar, Mira Mills, E.N.Clare Simpson, Angela Turner, Paul J. Bulfone-Paus, Silvia J Allergy Clin Immunol Article BACKGROUND: Food allergy is an increasing public health issue and the most common cause of life-threatening anaphylactic reactions. Conventional allergy tests assess for the presence of allergen-specific IgE, significantly overestimating the rate of true clinical allergy and resulting in overdiagnosis and adverse effect on health-related quality of life. OBJECTIVE: To undertake initial validation and assessment of a novel diagnostic tool, we used the mast cell activation test (MAT). METHODS: Primary human blood-derived mast cells (MCs) were generated from peripheral blood precursors, sensitized with patients' sera, and then incubated with allergen. MC degranulation was assessed by means of flow cytometry and mediator release. We compared the diagnostic performance of MATs with that of existing diagnostic tools to assess in a cohort of peanut-sensitized subjects undergoing double-blind, placebo-controlled challenge. RESULTS: Human blood-derived MCs sensitized with sera from patients with peanut, grass pollen, and Hymenoptera (wasp venom) allergy demonstrated allergen-specific and dose-dependent degranulation, as determined based on both expression of surface activation markers (CD63 and CD107a) and functional assays (prostaglandin D(2) and β-hexosaminidase release). In this cohort of peanut-sensitized subjects, the MAT was found to have superior discrimination performance compared with other testing modalities, including component-resolved diagnostics and basophil activation tests. Using functional principle component analysis, we identified 5 clusters or patterns of reactivity in the resulting dose-response curves, which at preliminary analysis corresponded to the reaction phenotypes seen at challenge. CONCLUSION: The MAT is a robust tool that can confer superior diagnostic performance compared with existing allergy diagnostics and might be useful to explore differences in effector cell function between basophils and MCs during allergic reactions. Mosby 2018-08 /pmc/articles/PMC6075471/ /pubmed/29518421 http://dx.doi.org/10.1016/j.jaci.2018.01.043 Text en © 2018 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bahri, Rajia
Custovic, Adnan
Korosec, Peter
Tsoumani, Marina
Barron, Martin
Wu, Jiakai
Sayers, Rebekah
Weimann, Alf
Ruiz-Garcia, Monica
Patel, Nandinee
Robb, Abigail
Shamji, Mohamed H.
Fontanella, Sara
Silar, Mira
Mills, E.N.Clare
Simpson, Angela
Turner, Paul J.
Bulfone-Paus, Silvia
Mast cell activation test in the diagnosis of allergic disease and anaphylaxis
title Mast cell activation test in the diagnosis of allergic disease and anaphylaxis
title_full Mast cell activation test in the diagnosis of allergic disease and anaphylaxis
title_fullStr Mast cell activation test in the diagnosis of allergic disease and anaphylaxis
title_full_unstemmed Mast cell activation test in the diagnosis of allergic disease and anaphylaxis
title_short Mast cell activation test in the diagnosis of allergic disease and anaphylaxis
title_sort mast cell activation test in the diagnosis of allergic disease and anaphylaxis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075471/
https://www.ncbi.nlm.nih.gov/pubmed/29518421
http://dx.doi.org/10.1016/j.jaci.2018.01.043
work_keys_str_mv AT bahrirajia mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis
AT custovicadnan mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis
AT korosecpeter mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis
AT tsoumanimarina mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis
AT barronmartin mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis
AT wujiakai mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis
AT sayersrebekah mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis
AT weimannalf mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis
AT ruizgarciamonica mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis
AT patelnandinee mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis
AT robbabigail mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis
AT shamjimohamedh mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis
AT fontanellasara mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis
AT silarmira mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis
AT millsenclare mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis
AT simpsonangela mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis
AT turnerpaulj mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis
AT bulfonepaussilvia mastcellactivationtestinthediagnosisofallergicdiseaseandanaphylaxis